Stock Ratings / Technology / HCTI / insiders

CYN (31) VS (38) ARBB (47) AUUD (47) ⌘ Pro Terminal →

Healthcare Triangle Inc. (HCTI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Q: Is HCTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Healthcare Triangle Inc. (NASDAQ: HCTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $6.30 (-2.02% 1D, market cap $5.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, HCTI ranks #697 in composite RQD confidence.

Q: How does HCTI compare to CYN and VS in the Technology sector?

Within the Technology sector (EDP Services), HCTI carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, CYN (Cyngn Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $5.6M) and VS (Versus Systems Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -17.7%, cap $5.3M). Among the 5-stock peer group, HCTI leads on earnings multiple (N/A) while VS leads on capital efficiency (-17.7% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for HCTI?

Per HCTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839285), Healthcare Triangle Inc. generated $13.9M in revenue (+18.8% YoY), -$9.5M in net income, and -$16.5M in free cash flow against $22.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is HCTI trading relative to its 50-day, 200-day, and 52-week technical levels?

HCTI last traded at $6.30 (-2.02% on volume of 18,899 shares), positioning the stock -50.35% below its 50-day simple moving average ($12.69) and -90.77% below its 200-day simple moving average ($68.27). Across its 52-week range of $5.14 to $3,390.00, HCTI sits at the 0.0% percentile with a 14-day RSI of 24.9 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($5.51 to $7.09).

Q: Are HCTI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies HCTI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

$6.30 -2.02% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.27

Healthcare Triangle Inc. (HCTI) carries a Roarable Rating of E (Strong Sell) with 27/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (27/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $5.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $6.27 (-0.55%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (27/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.3% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-14% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HCTI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (27/100 Composite)

🔍 WHY HCTI SCORES 27/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (48% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 24.9 (OVERSOLD (<32))

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (33% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$9.66-17.6% Next Q

Q2 (-2Q)

Grade E$7.96-15.6% Next Q

Q3 (-1Q)

Grade E$6.72-6.2% Next Q

Current

Grade E$6.30-10.3% Hist 90D α

Trajectory: E (35) → E (27)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a HCTI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While HCTI currently carries a cautious 27/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($12.69) and Max Pain ($6.62) forces dealer call-delta covering toward $3,559.50.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HCTI• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HCTI Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 27%NO 73%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

HCTI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (HCTI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on HCTI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HCTI)

✓Walkthrough of HCTI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HCTI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -86.12%📐 HORIZONTAL RANGE

2026-10-30O $6.17H $6.30L $5.14C $6.30VOL 11.9K

RES: $66.51SUP: $-4.52SMA50: $12.69SMA200: $68.27

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HCTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HCTI Butterfly Map → + Track HCTI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HCTI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HCTI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HCTI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HCTI)

Technology Rank #697 of 714 ⚔️ CYN vs HCTI Full Matrix →

1. Head-to-Head Technology Peer Comparison (HCTI vs. CYN, VS, ARBB, AUUD)

Industry: EDP Services (163 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Healthcare Triangle Inc. (HCTI) ranks #697 by composite RQD confidence (27/100, grade E) and #671 by equity capitalization ($5.6M). Within this direct 5-issuer industry benchmark cohort, HCTI leads on earnings valuation at N/A trailing P/E, while VS leads on capital efficiency and profitability with -17.7% ROIC and 96.0% gross margin. ARBB currently holds the highest overall quantitative score in the immediate peer group at 47/100 (D) compared with HCTI at 27/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HCTI ACTIVE Healthcare Triangle Inc.	E	27/100	—	96.0%	-35.0%	-2.02%	$5.6M	Benchmark Subject
CYN Cyngn Inc.	E	31/100	—	38.0%	-35.0%	-6.84%	$5.6M	/cyn-vs-hcti →
VS Versus Systems Inc.	D-	38/100	—	96.0%	-17.7%	-11.92%	$5.3M	/vs-vs-hcti →
ARBB ARB IOT Group Limited	D	47/100	—	—	—	-10.03%	$6.2M	/arbb-vs-hcti →
AUUD Auddia Inc.	D	47/100	—	—	-35.0%	+0.32%	$4.9M	/auud-vs-hcti →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001839285

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Healthcare Triangle Inc. (HCTI) reported GAAP revenue of $13.9M (+18.8% vs. FY2024 revenue of $11.7M , and -58.2% cumulative change since FY2023) , GAAP net income of -$9.5M, operating cash flow of -$16.5M, and free cash flow of -$16.5M (-1429.0% YoY). On the balance sheet, HCTI closed FY2025 with $22.7M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$13.9M	-$9.5M	-$16.5M	-$16.5M	$22.7M	—
FY2024 (FY)	2024-12-31	$11.7M	-$6.0M	-$1.1M	-$1.1M	$2.0M	—
FY2023 (FY)	2023-12-31	$33.2M	-$8.7M	-$2.2M	-$2.2M	—	—

3. HCTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HCTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Healthcare Triangle Inc. (NASDAQ: HCTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $6.30 (-2.02% 1D, market cap $5.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, HCTI ranks #697 in composite RQD confidence.

How does HCTI compare to CYN and VS in the Technology sector?

Within the Technology sector (EDP Services), HCTI carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, CYN (Cyngn Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $5.6M) and VS (Versus Systems Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -17.7%, cap $5.3M). Among the 5-stock peer group, HCTI leads on earnings multiple (N/A) while VS leads on capital efficiency (-17.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HCTI?

Per HCTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839285), Healthcare Triangle Inc. generated $13.9M in revenue (+18.8% YoY), -$9.5M in net income, and -$16.5M in free cash flow against $22.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HCTI trading relative to its 50-day, 200-day, and 52-week technical levels?

HCTI last traded at $6.30 (-2.02% on volume of 18,899 shares), positioning the stock -50.35% below its 50-day simple moving average ($12.69) and -90.77% below its 200-day simple moving average ($68.27). Across its 52-week range of $5.14 to $3,390.00, HCTI sits at the 0.0% percentile with a 14-day RSI of 24.9 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($5.51 to $7.09).

HCTI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are HCTI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies HCTI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: HCTI RQD Cockpit HCTI 12M Forecast HCTI Earnings & Move HCTI Dividends & DRIP HCTI Insiders & 13F HCTI Whale Options HCTI Profit Sankey HCTI News & Why